Literature DB >> 6188922

Effects of drugs on beta-adrenergic receptors on human lymphocytes.

P B Molinoff, R D Aarons.   

Abstract

The density of beta-adrenergic receptors has been determined on membranes prepared from lymphocytes of normal human volunteers. Long-term administration of propranolol resulted in an increase in the density of receptors, whereas administration of the agonists ephedrine and terbutaline elicited a marked decrease in the density of receptors. These changes may explain the delayed side effects observed when propranolol administration is abruptly discontinued and the decreased efficacy that occurs during long-term administration of an agonist. In other experiments, pindolol, an antagonist with intrinsic sympathomimetic activity, was administered to normal subjects. A marked decrease in the density of receptors occurred within 1 day of administering pindolol. This effect persisted beyond the time at which pindolol administration was discontinued.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6188922     DOI: 10.1097/00005344-198300051-00010

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  12 in total

Review 1.  Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery.

Authors:  R A de Ligt; A P Kourounakis; A P IJzerman
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Does treatment with beta-adrenergic blocking agents cause a decrease in beta 2-adrenoceptor affinity?

Authors:  W M Blankesteijn; S J Graafsma; M P Hectors; E A Olde Riekerink; J F Rodrigues de Miranda; T Thien
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  [How many beta-receptor blockers does the physician need?].

Authors:  D Palm
Journal:  Klin Wochenschr       Date:  1987-03-16

4.  Comparison of changes in the characteristics of beta-adrenoceptors and responsiveness of human circulating lymphocytes during and after chronic administration of pindolol and propranolol.

Authors:  Y Giudicelli; D Lacasa; B Agli; A Leneveu
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Adimolol, a long acting beta-adrenoceptor blocker in man.

Authors:  H L Elliott; C R Jones; N M Deighton; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

6.  The role of endogenous noradrenaline in the beta-blocker withdrawal phenomenon--studies with cultured heart cells.

Authors:  C Reithmann; A Thomschke; K Werdan
Journal:  Klin Wochenschr       Date:  1987-04-01

Review 7.  Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation.

Authors:  P B Molinoff
Journal:  Drugs       Date:  1984       Impact factor: 9.546

8.  Effects of chronic metoprolol and sulphinpyrazone on human lymphocyte beta-adrenoceptors.

Authors:  A De Blasi; M Cortellaro; C Costantini
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

9.  Effects of beta-adrenoceptor antagonist administration on beta 2-adrenoceptor density in human lymphocytes. The role of the "intrinsic sympathomimetic activity".

Authors:  O E Brodde; A Daul; N Stuka; N O'Hara; U Borchard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

10.  Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.

Authors:  O E Brodde; R Schemuth; M Brinkmann; X L Wang; A Daul; U Borchard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.